Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TPIV 200 |
Synonyms | |
Therapy Description |
TPIV 200 is a peptide vaccine that targets the folate receptor 1 (FOLR1) to activate cytotoxic T-lymphocytes against tumor cells overexpressing FOLR1 (PMID: 27294608). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TPIV 200 | TPIV200|TPIV-200 | FOLR1-targeted Therapy 24 | TPIV 200 is a peptide vaccine that targets the folate receptor 1 (FOLR1) to activate cytotoxic T-lymphocytes against tumor cells overexpressing FOLR1 (PMID: 27294608). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|